Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-24

Clinical Trial Update: A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium [Phase 3]

View source ↗

Summary

Clinical trial update for CBT-001 in pterygium (Phase 3); the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CBT-001

Snippet

Sponsor: Cloudbreak Therapeutics, LLC | Conditions: Pterygium | Phase 3 | Status: ACTIVE_NOT_RECRUITING